← 返回

肿瘤细胞释放的自噬体(TRAP)通过 C3a 编程炎症性 CAFs,驱动免疫排斥型 TIME

英文原题:Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a.

查看英文原题

Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a.

PubMed 2026/07/29(内容时间) Cell Mol Immunol Q1 · IF 23.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫排斥型肿瘤免疫微环境(TIME)限制了对ICIs的应答。癌相关成纤维细胞是最丰富的基质细胞群体,也是免疫抑制的关键调控者;然而,编程致病性CAF状态的上游信号以及免疫排斥型TIME的机制仍不明确。

在此,我们通过结合单细胞RNA测序和功能验证,报道肿瘤细胞释放的自噬体(TRAP)编程炎症性CAFs(iCAFs),并通过HSP70-TLR4-MyD88-ERK/p38通路触发组织蛋白酶L依赖的细胞内C3切割为C3a。iCAF来源的C3a作用于TAMs上的C3a,促进TAM在富含iCAF的基质中积聚,限制TIL向肿瘤巢的转运,并强化免疫排斥型TIME。破坏TRAP-iCAF-C3a/C3aR轴可重塑免疫排斥型TIME并使肿瘤对抗PD-L1治疗敏感。在临床队列中,血浆TRAP和C3a水平随疾病分期增加,且二者联合提高了乳腺癌患者与对照者的区分能力(AUC = 0.96)。这些数据定义了一个促进免疫排斥的TRAP驱动的基质-免疫回路,并提示C3a-C3aR轴是增强ICI疗效的潜在靶点。

展开英文摘要原文

The immune-excluded tumor immune microenvironment (TIME) limits responses to ICIs. Cancer-associated fibroblasts are the most abundant stromal population and key regulators of immune suppression; however, the upstream cues that program pathogenic CAF states and the mechanisms of the immune-excluded TIME remain poorly defined.

Here, by combining single-cell RNA sequencing and functional validation, we report that tumor cell-released autophagosome (TRAP) programs inflammatory CAFs (iCAFs) and triggers cathepsin L-dependent intracellular cleavage of C3 into C3a via the HSP70-TLR4-MyD88-ERK/p38 pathway. iCAF-derived C3a affects C3a on TAMs, promotes TAM accumulation in the iCAF-rich stroma, limits TIL trafficking into tumor nests, and reinforces an immune-excluded TIME.

Disrupting the TRAP-iCAF-C3a/C3aR axis remodels the immune-excluded TIME and sensitizes tumors to anti-PD-L1 therapy. In clinical cohorts, plasma TRAP and C3a levels increased with disease stage, and their combination improved the discrimination of patients with breast cancer from controls (AUC = 0. 96). These data define a TRAP-driven stromal-immune circuit that promotes immune exclusion and suggest that the C3a-C3aR axis is a potential target for enhancing ICI efficacy.

论文信息

作者
Wang X、Wei Y、Wu C、Zhou X、Sun X、Du X、Chen J、Chen J
第一作者单位
Department of Microbiology and Immunology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.China
通讯作者单位
Department of Microbiology and Immunology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. lxwang@seu.edu.cn.China
文献类型
非美国政府资助研究
期刊
Cellular & molecular immunology2026 Sep
原文标识
PubMed 42527662 · DOI 10.1038/s41423-026-01452-5